Opioid Withdrawal Management Market
Opioid Withdrawal Management Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Opioid Withdrawal Management Market Size and Growth
The Opioid Withdrawal Management market is experiencing significant growth, driven by increasing opioid addiction rates and heightened awareness of treatment options. The market is projected to reach approximately $1.5 billion by 2025, reflecting escalating demand for effective withdrawal solutions and integrated care approaches in response to the opioid crisis.
Companies Covered
(Covid 19 Impact Covered)
◍ Alkermes
◍ Orexo
◍ Financiere Verdi
◍ Indivior
◍ Mylan
◍ Sun Pharmaceutical Industries
◍ Teva
◍ Dr. Reddy’s Laboratories
◍ BioDelivery Sciences
◍ Rhodes Pharmaceuticals
◍ Hikma Pharmaceuticals
◍ Actavis Elizabeth
◍ Mallinckrodt Pharmaceuticals
The Opioid Withdrawal Management Market is competitive, featuring companies like Alkermes, Orexo, and Indivior, which develop medications such as buprenorphine and naltrexone. These firms advance treatment options, enhancing patient adherence and outcomes. Notable sales figures include Indivior’s 2022 revenue of $734 million and Alkermes' $844 million. Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Others
Request Sample Report
By Product
Natural Withdrawal
Drug Treatment
Others
Market Growth
Request Sample Report
$ 0.86 Billion
